01235 832023
Source MS Trust: Action potential simulation is a complementary therapy which some people use as a treatment for pain in MS. It’s available at some MS Therapy Centres in the UK. (Note: We offer this at BMSTC, find out more about our service here.) Action potential is the term used to describe the moment when signals –… Read more »
Source MS Trust: A recent review has outlined the progress made so far in understanding the biology of remyelination, what goes wrong in MS, some of the research problems that need to be tackled and the prospect for treatments in the not-too-distant future. Considerable progress has been made in understanding the biology of remyelination. This has… Read more »
Source MS Trust: People with neurological conditions are facing long waiting times, limited access to specialists, poor mental health support and a failing social care system, according to a new survey by The Neurological Alliance. The National Neurology Patient Experience Survey presents a picture of the experiences of people living with a neurological condition in England. … Read more »
Source Medical Xpress: A new study has shown that people in the advanced stage of multiple sclerosis (MS) experience significant improvements in movement and balance thanks to a specialised standing frame. Led by the University of Plymouth and published today in The Lancet Neurology, the study in people with progressive MS also showed that the intervention appeared… Read more »
Source MS Trust: Finding the right holiday for you. It’s that time of year when everyone is jetting off on holiday, but when you have MS there’s often a bit more planning involved before you can pack up your suitcase and head to the beach. Where can you find accessible accommodation and attractions? How do you… Read more »
Source m.phys.org: A nanotechnology treatment derived from bone marrow stem cells has reversed multiple sclerosis symptoms in mice and could eventually be used to help humans, according to a new study led by the University of California, Irvine researchers. “Until now, stem cell therapies for autoimmune and neurodegenerative diseases have produced mixed results in clinical trials, partly because… Read more »
Source Science Daily: Researchers have found mutations in 12 genes believed to be largely responsible for the onset of multiple sclerosis in families with multiple members diagnosed with the disease. An international team of researchers led by the University of British Columbia has made a scientific advance they hope will lead to the development of preventative… Read more »
We take care of your NHS Repeat Prescriptions. With easy online ordering, free flexible delivery and reminders to re-order. Get your NHS repeat prescriptions delivered FREE to your door. We arrange and deliver your NHS repeat prescriptions to your door – for free. The Electronic Prescription Service is an NHS service which allows you to… Read more »
Source UCLH.nhs.uk: UCLH’s Biomedical Research Centre has supported the development of a new artificial intelligence-based method for detecting the brain’s response to treatment in multiple sclerosis (MS) that is substantially better than what a human expert is able to do using conventional techniques, representing potentially ‘superhuman’ performance in the task. UCL researchers – led by Dr… Read more »
Source MS Trust: The MS Trust is delighted that Ocrevus (ocrelizumab) has been approved by NICE for NHS treatment of early, inflammatory primary progressive MS. NICE has approved Ocrevus for people with primary progressive MS if they: have had symptoms of primary progressive MS for 15 years or less and are able to walk 20 metres or more, with or without walking aids (up… Read more »